Meet Nushama, New York’s new operator of medically supervised psychedelic wellness clinics for sustained depression, anxiety, chronic pain, addiction and trauma-induced mood disorders relief.
Two Locations So Far
Currently at 1111 Park Avenue in Manhattan and 7401 4th Avenue in Brooklyn, with a Madison Ave HQ opening in September, Nushama provides professionally administered, high-dose ketamine intravenous and intramuscular treatments in a serene, safe environment.
The startup offers integration and access, collaborating with therapists, practitioners, and providers to support their clients’ treatment plans while connecting their own patients to mental health practitioners that meet their needs.
“Mental wellness has reached a tipping point in mainstream media and culture,” Jay Godfrey, co-founder of Nushama told Benzinga. “We want to make mental wellness available to everyone. We are working with world-renowned doctors, focused exclusively on patient care. While we provide a psychedelic journey that is well-documented to treat depression, PTSD, addiction, and pain conditions, many instances of trauma-related OCD, eating disorders, and IBS can also benefit.”
Encuentra nuestro contenido en Español en El Planteo:
- Ketamina: Todo lo que Siempe Quisiste Saber y Nunca te Animaste a Preguntar
- Canadá: Obra Social Cubrirá Tratamientos con Ketamina para la Depresión
Courtesy photo.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.